Bildnachweis: Rivermark Medical.Andera Partners has led a 20 million USD Series D financing round in Rivermark Medical, underscoring continued investor confidence in minimally invasive therapies for benign prostatic hyperplasia (BPH). The financing round, which also drew participation from existing
Bildnachweis: Topadur Pharma AG.The mission of the Swiss biopharmaceutical Topadur is not only to dilate blood vessels, but also to cause them to regenerate. Its innovative drugs, partly already in clinical development, have the potential to delay or prevent debilitating diseases and extend healthy
Bildnachweis: Dr. Holger Bengs, BCNP Consultants.Public funding mitigates risks, but it cannot replace equity. Life sciences founders who merely jump from one funding deadline to the next, or who masquerade as tech companies for investors, lose sight of what matters most: the market. In our intervie
Bildnachweis: Foto von ThisisEngineering auf Unsplash.Drug development, medical technology, or digital health: few industries are as capital-intensive as the life sciences. Yet, knowing precisely when to submit which application can drastically reduce burn rates and effectively extend a start-up’s r
Bildnachweis: Swiss Biotech Association.The Swiss Biotech Day 2026 has kicked off in Basel from May 4-5, once again positioning Switzerland at the center of the global biotech dialogue. Over two days more than 3,000 industry leaders, investors and scientists from around the world have gathered to di
Bildnachweis: Swiss Biotech Association.Switzerland’s biotech sector delivered a robust performance in 2025, underlining its resilience in a challenging global environment. According to the Swiss Biotech Report 2026, unveiled at the Swiss Biotech Day 2026 in Basel by the Swiss Biotech Association in
Bildnachweis: Siegfried.DINAMIQS, a Siegfried company (SIX: SFZN), announces that it has received the manufacturing and testing license from Swissmedic for viral vector cGMP production. With this approval, DINAMIQS is now authorized to manufacture and release Advanced Therapeutic Medicinal Products
Bildnachweis: Primogene.Das Leipziger Biotech-Start-up Primogene GmbH hat 4,1 Mio. EUR im Rahmen einer Seedfinanzierung eingesammelt. Das Kapital soll helfen, seine komplexen bioaktiven Moleküle in industriellem Maßstab auf den Markt zu bringen. Mithilfe einer enzymatischen Plattformtechnologie pro
Bildnachweis: mbiomics, MIG Capital.Das Start-up mbiomics, das skalierbare, mikrobiombasierte Therapeutika für schwere und chronische Erkrankungen entwickelt, hat im dritten Abschluss seiner Serie-A-Finanzierungsrunde weitere 12 Mio. EUR eingesammelt. Damit summiert sich das Gesamtvolumen der Runde
Bildnachweis: Pavel Elizarev (Smey) & Christian Gnam (IZB).In the biotech world, yeast is often hailed as the ‘factory of the future’. Martinsried-based start-up Smey is turning that vision into an industrial reality. By developing sustainable alternatives to traditional fats and oils, Smey is tackl
Bildnachweis: W&B/Markus Braumann.Isartal Health Media und Forte bauen ihre strategische Zusammenarbeit aus und gründen das Digital-Health-Powerhouse „Forte Health“. Ziel ist es, die digitale Transformation im Gesundheitswesen gezielt und skalierbar voranzutreiben.Forte Health soll Akteure im Gesund
Bildnachweis: (c) Promatix.Promatix Biosciences presented new data at American Association for Cancer Research (AACR) Annual Meeting 2026, addressing a key bottleneck in the development of antibody–drug conjugates (ADCs): the scarcity of truly tumour-selective targets. The UK-based biotech company
Bildnachweis: Dr Manja Epping & Dr Stefanie Greifeneder (Heuking) & Martin Krauss (FGK).Together with leading chinical research and legal experts, we analyse: is Brussels‘ 75-day fast-track enough to stop the innovation drain, or does the lack of capital remain the true bottleneck?The EU Biotech Act
Bildnachweis: LEYTON, VentureCapital Magazin, Pixabay.When the pandemic broke out in 2020, medical research around the world was under intense pressure. Everything had to happen at once: the so-called CMC development of a therapeutic antibody, preclinical testing in the laboratory and, finally, clin
Bildnachweis: D.B.T..Am 21. und 22. April trifft sich die deutsche und europäische Biotech-Branche in Leipzig. Rund 1000 internationale Teilnehmer aus Wissenschaft, Wirtschaft, Politik, Administration und Medien werden im Kongresszentrum am Zoo zu den German Biotech Days 2026 erwartet, um aktuelle F
Bildnachweis: CorTec.CorTec GmbH, a pioneer in fully implantable brain-computer interfaces (BCI), announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its proprietary Brain Interchange™ System. The designation specifically targets the use of direc
Bildnachweis: Tubulis.US biopharmaceutical giant Gilead Sciences is acquiring the biotech start-up Tubulis, significantly expanding its oncology division. The transaction includes an upfront cash payment of $3.15 billion, supplemented by potential milestone payments of up to $1.85 billion, bringing
Bildnachweis: bio:cap.A new international platform in Berlin connects investors, start-ups and research to accelerate venture creation in biotechnology and artificial intelligence. Artificial intelligence is transforming biotechnology, diagnostics and drug discovery. At the same time, Europe is comp
Bildnachweis: Dr. Jinling Chen, WuXi AppTec.At WuXi AppTec’s Couvet site in Switzerland, an integrated CRDMO approach is being designed to accelerate the path from discovery to commercial manufacturing. Dr Jinling Chen explains how combining research, development, and manufacturing helps life scienc
Bildnachweis: vectorfusionart – stock.adobe.com.BSM Biotech Holding GmbH has officially launched operations, positioning itself as a venture builder focused on translating academic research into first-in-class therapeutic assets.Headquartered in Grainau, Germany, BSM aims to identify promising molec
Bildnachweis: VentureCapital Magazin, Pixabay.Like a sword of Damocles, a concern hangs over every life sciences start-up founded in Germany: will the company remain headquartered in Germany – and with it the underlying technology – or is there a risk of relocation abroad? This issue is not only on
Bildnachweis: Life Science Factory.Ein Jahr nach dem Start am Helmholtz-Standort in München baut die Life Science Factory ihre Position als Inkubator für Life-Science-Start-ups weiter aus. Seit Februar 2025 ist die Zahl der ansässigen Teams von zunächst drei auf aktuell zwölf gestiegen. Auf rund 1.8
Bildnachweis: ECBF.Bioeconomy-focused venture capital investor ECBF VC has opened an office in Paris and unveiled a renewed brand identity. With this step, the fund aims to further strengthen its position as a leading European VC platform for the bioeconomy and expand its activities in France.France
Bildnachweis: FGK Clinical Research.FGK Clinical Research is strengthening its European footprint with an operational presence in the Netherlands. The Munich-headquartered contract research organisation (CRO) is expanding its operative team to support clinical studies for international clients and t
